Search

everythinglearnresearchcommunity

for

Search:↓

Electrospun nanofibers show promise for enhancing blood vessel growth in tissue engineering but need further research to improve their effectiveness.

The document concludes that for hair and feather growth, it's better to target the environment around stem cells than the cells themselves.

PRP injections may be a safe, effective alternative for hair loss treatment compared to minoxidil and finasteride.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Some drugs may reduce prostatitis symptoms short-term with few side effects.

The document concludes that recognizing and properly diagnosing lipodystrophy syndromes is crucial for effective management and treatment.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

The protein StAR is found in 17 different organs and can affect hair loss and brain functions, but its full role is not yet fully understood.

Hair loss treatments work better with lifestyle changes.

Stretching skin increases a certain protein that attracts stem cells, helping skin regeneration.

A disease causing skin issues in young adult German short-haired pointers is hereditary, with most affected dogs not responding to treatment.

The document concludes that terbinafine is effective for treating scalp fungal infections in children and recommends not excluding them from school during treatment, while also highlighting the need for updated treatment guidelines due to changing infection patterns.

STAT5 activation is crucial for starting the hair growth phase.

Topical tofacitinib may grow hair better than minoxidil by increasing VEGF and reducing inflammation.

Consider benefits and risks of new alopecia treatments for safety.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

Steroid sulfatase is important for activating hormones that affect memory, brain function, and certain diseases, and could be a target for treating hormone-related disorders.

Sargassum muticum extract and its component apo-9'-fucoxanthinone may help hair growth and treat hair loss.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Canine epidermal neural crest stem cells could be a promising treatment for spinal cord injuries in dogs.

Various treatments, including FDA-approved drugs, natural products, and oral supplements, can help with hair loss, but a patient's medical history and potential allergies should be considered when choosing a treatment.

PRP and cell therapies may help with hair loss, but more research is needed.

Taking Propecia might lead to the development of cataracts.

Rare changes in the KRT82 gene are linked to a higher risk of Alopecia Areata.

Adding cells to fat grafts improves hair regrowth in early baldness, but effects lessen over time.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.